Assessing the impact of COVID-19 on liver cancer management (CERO-19)
2021 · JHEP Reports · 65 citations
https://doi.org/10.1016/j.jhepr.2021.100260
M
Maria Guarino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
2.6K
Citations
27
h-index
75
i10-index
Maria Guarino is an academic researcher from Istituto delle Scienze Neurologiche di Bologna. The author has contributed to research in topics: Neurological Complications and Syndromes & Acute Ischemic Stroke Management & CAR-T cell therapy research. The author has an h-index of 27, co-authored 151 publications.
ORCID: 0000-0002-8894-2187Papers by this author
worksNonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets
2015 · Vascular Pharmacology · 20 citations
https://doi.org/10.1016/j.vph.2015.06.016
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity
2018 · Thrombosis and Haemostasis · 16 citations
https://doi.org/10.1055/s-0038-1629920
Comparison of Allplex™ SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19
2021 · International Journal of Infectious Diseases · 15 citations
https://doi.org/10.1016/j.ijid.2021.09.069
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation
2020 · Journal of Thrombosis and Thrombolysis · 13 citations
https://doi.org/10.1007/s11239-020-02214-4
MiR‐21 role in aspirin‐dependent PPARα and multidrug resistance protein 4 upregulation
2018 · Research and Practice in Thrombosis and Haemostasis · 10 citations
https://doi.org/10.1002/rth2.12104
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat